drugset / Trial / NCT00512278

Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C

NCT00512278

Phase 2 Completed 146 enrolled Nizar Zein Centocor, Inc. · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of the study is to investigate in subjects receiving their first course of peg-interferon α-2b plus ribavirin therapy for chronic HCV infection

Timeline

Start
2007-07
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Infliximab Monoclonal antibody Other